Co-clustering of Fcgamma and B Cell Receptors Induces Dephosphorylation of the Grb2-associated Binder 1 Docking Protein
Overview
Affiliations
The immunoreceptor tyrosine-based inhibitory motif (ITIM) of human type IIb Fcgamma receptor (FcgammaRIIb) is phosphorylated on its tyrosine upon co-clustering with the B cell receptor (BCR). The phosphorylated ITIM (p-ITIM) binds to the SH2 domains of polyphosphoinositol 5-phosphatase (SHIP) and the tyrosine phosphatase, SHP-2. We investigated the involvement of the molecular complex composed of the phosphorylated SHIP and FcgammaRIIb in the activation of SHP-2. As a model compound, we synthesized a bisphosphopeptide, combining the sequences of p-ITIM and the N-terminal tyrosine phosphorylated motif of SHIP with a flexible spacer. This compound bound to the recombinant SH2 domains of SHP-2 with high affinity and activated the phosphatase in an in vitro assay. These data suggest that the phosphorylated FcgammaRII-SHIP complexes formed in the intact cells may also activate SHP-2. Grb2-associated binder 1 (Gab1) is a multisite docking protein, which becomes tyrosine-phosphorylated in response to various types of signaling, including BCR. In turn it binds to the SH2 domains of SHP-2, SHIP and the p85 subunit of phosphatidyl inositol 3-kinase (PtdIns3-K) and may regulate their activity. Gab1 is a potential substrate of SHP-2, thus its binding to FcgammaRIIb may modify the Gab1-bound signaling complex. We show here that Gab1 is part of the multiprotein complex assembled by FcgammaRIIb upon its co-clustering with BCR. Gab1 may recruit SH2 domain-containing molecules to the phosphorylated FcgammaRIIb. SHP-2, activated upon the binding to FcgammaRIIb-SHIP complex, partially dephosphorylates Gab1, resulting in the release of PtdIns3-K and ultimately in the inhibition of downstream activation pathways in BCR/FcgammaRIIb co-aggregated cells.
Dissecting phospho-motif-dependent Shc1 interactome using long synthetic protein fragments.
Chen P, Chen X, Song X, He A, Zheng Y, Li X Chem Sci. 2024; .
PMID: 39184293 PMC: 11342145. DOI: 10.1039/d4sc02350a.
Bobone S, Storti C, Calligari P, Stella L Methods Mol Biol. 2023; 2705:93-112.
PMID: 37668971 DOI: 10.1007/978-1-0716-3393-9_6.
Revealing Allostery in PTPN11 SH2 Domains from MD Simulations.
Anselmi M, Hub J Methods Mol Biol. 2023; 2705:59-75.
PMID: 37668969 DOI: 10.1007/978-1-0716-3393-9_4.
The regulators of BCR signaling during B cell activation.
Wen Y, Jing Y, Yang L, Kang D, Jiang P, Li N Blood Sci. 2022; 1(2):119-129.
PMID: 35402811 PMC: 8975005. DOI: 10.1097/BS9.0000000000000026.
Bobone S, Pannone L, Biondi B, Solman M, Flex E, Canale V J Med Chem. 2021; 64(21):15973-15990.
PMID: 34714648 PMC: 8591604. DOI: 10.1021/acs.jmedchem.1c01371.